RegeneRx Biopharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
J. Finkelstein
Chief executive officer
US$165.3k
Total compensation
| CEO salary percentage | 44.7% |
| CEO tenure | 22.1yrs |
| CEO ownership | 1.2% |
| Management average tenure | no data |
| Board average tenure | 21yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$165k | US$74k | -US$2m |
| Sep 30 2022 | n/a | n/a | -US$2m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$204k | US$80k | -US$2m |
| Sep 30 2021 | n/a | n/a | -US$2m |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | n/a | n/a | -US$2m |
| Dec 31 2020 | US$179k | US$80k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$2m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$1m |
| Dec 31 2019 | US$188k | US$82k | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$1m |
| Dec 31 2018 | US$145k | US$102k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$312k |
| Jun 30 2018 | n/a | n/a | -US$1m |
| Mar 31 2018 | n/a | n/a | -US$809k |
| Dec 31 2017 | US$184k | US$150k | US$286k |
Compensation vs Market: J.'s total compensation ($USD165.26K) is below average for companies of similar size in the US market ($USD670.12K).
Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.
CEO
J. Finkelstein (71 yo)
22.1yrs
Tenure
US$165,262
Compensation
Mr. J. J. Finkelstein has been the Chief Executive Officer and President of Regenerx Biopharmaceuticals Inc. since March 19, 2002 and has been its Director since 2002. Mr. Finkelstein has been responsible...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 42.3yrs | US$156.54k | 1.06% $ 22.4 | |
| President | 22.3yrs | US$165.26k | 1.17% $ 24.8 | |
| Independent Director | 22.3yrs | US$40.64k | 4.32% $ 91.3 | |
| Independent Director | 19.8yrs | US$33.64k | 0% $ 0 | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 13.6yrs | US$40.64k | 0.069% $ 1.5 | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 5.1yrs | US$33.64k | 0% $ 0 |
21.0yrs
Average Tenure
71yo
Average Age
Experienced Board: RGRX's board of directors are seasoned and experienced ( 21 years average tenure).